Panama approves Pfizer COVID-19 booster for high-risk people | Inquirer News
Close  

Panama approves Pfizer COVID-19 booster for high-risk people

/ 10:32 AM October 13, 2021
pfizer vaccine

A woman holds a small bottle labeled with a “Coronavirus COVID-19 Vaccine” sticker and a medical syringe in front of displayed Pfizer logo in this illustration taken, October 30, 2020. REUTERS FILE PHOTO

PANAMA CITY — Panama has approved a booster dose of Pfizer Inc’s COVID-19 vaccine for high-risk people, including healthcare workers, bedridden patients, nursing home residents and people over 55, health officials said on Tuesday.

The Central American country has reported 469,440 COVID-19 infections since the start of the pandemic and 7,275 deaths. More than 5.5 million vaccine doses have been administered since January, covering most of the eligible population.

ADVERTISEMENT

“We have decided to begin the process of applying a booster shot to the population with the Pfizer vaccine, starting tomorrow in public and private hospitals,” Health Minister Luis Sucre said.

The booster shot will be offered to people who received their second dose at least six months before and will target those at high risk of developing complications from the virus, he added.

FEATURED STORIES

RELATED STORIES

Pfizer COVID vaccine booster dose okayed for Americans aged 65 and older

WHO: No need for booster shots yet except for immunocompromised

Subscribe to our daily newsletter


Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: COVID-19 Vaccine Booster, Health, Panama, Pfizer
For feedback, complaints, or inquiries, contact us.



© Copyright 1997-2022 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.